Viewing Study NCT03445832


Ignite Creation Date: 2025-12-24 @ 9:49 PM
Ignite Modification Date: 2025-12-25 @ 7:27 PM
Study NCT ID: NCT03445832
Status: COMPLETED
Last Update Posted: 2018-08-17
First Post: 2018-02-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Pulmonary Function and Neuromuscular Disease
Sponsor: Centre Hospitalier Universitaire de Besancon
Organization:

Study Overview

Official Title: Pulmonary Function and Neuromuscular Disease
Status: COMPLETED
Status Verified Date: 2018-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PREMDEN
Brief Summary: This study aims to describe the evolution of pulmonary function in 3 neuromuscular diseases : Duchenne muscular dystrophy, Werdnig-Hoffinann disease, congenital myopathy, monitored in Besançon university hospital.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: